tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HALO Stock Latest News

Halozyme Therapeutics’ Earnings Call Highlights Robust Growth
Company AnnouncementsHalozyme Therapeutics’ Earnings Call Highlights Robust Growth
8d ago
HALO
Halozyme’s Strong Financial Performance and Growth Prospects Lead to Buy Rating and Increased Price Target
PremiumRatings
Halozyme’s Strong Financial Performance and Growth Prospects Lead to Buy Rating and Increased Price Target
9d ago
HALO
Halozyme’s Strong Financial Performance and Growth Prospects Lead to Buy Rating
PremiumRatings
Halozyme’s Strong Financial Performance and Growth Prospects Lead to Buy Rating
9d ago
HALO
Halozyme price target raised to $75 from $72 at H.C. Wainwright
PremiumThe Fly
Halozyme price target raised to $75 from $72 at H.C. Wainwright
9d ago
HALO
Halozyme upgraded to Overweight from Equal Weight at Morgan Stanley
PremiumThe Fly
Halozyme upgraded to Overweight from Equal Weight at Morgan Stanley
9d ago
HALO
Halozyme Therapeutics Reports Strong Q2 2025 Results
PremiumCompany AnnouncementsHalozyme Therapeutics Reports Strong Q2 2025 Results
9d ago
HALO
Positive Outlook and Strong Performance Drive Buy Rating for Halozyme
Premium
Ratings
Positive Outlook and Strong Performance Drive Buy Rating for Halozyme
9d ago
HALO
Halozyme reports Q2 non-GAAP EPS $1.54, consensus $1.23
Premium
The Fly
Halozyme reports Q2 non-GAAP EPS $1.54, consensus $1.23
10d ago
HALO
Halozyme raises FY25 non-GAAP EPS view to $6.00-$6.40 from $5.30-$5.70
PremiumThe Fly
Halozyme raises FY25 non-GAAP EPS view to $6.00-$6.40 from $5.30-$5.70
10d ago
HALO
Halozyme Therapeutics (HALO) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Halozyme Therapeutics (HALO) Q2 Earnings Cheat Sheet
12d ago
HALO
Halozyme’s Promising Cancer Study: A Potential Game-Changer in Oncology
PremiumCompany Announcements
Halozyme’s Promising Cancer Study: A Potential Game-Changer in Oncology
21d ago
HALO
Halozyme says EU approves new indication for Janssen’s Darzalex Faspro
PremiumThe Fly
Halozyme says EU approves new indication for Janssen’s Darzalex Faspro
23d ago
JNJ
HALO
Hold Rating for Halozyme Amid CMS Pricing Uncertainty and Regulatory Concerns
PremiumRatingsHold Rating for Halozyme Amid CMS Pricing Uncertainty and Regulatory Concerns
24d ago
HALO
Halozyme resumed with a Neutral at Goldman Sachs
Premium
The Fly
Halozyme resumed with a Neutral at Goldman Sachs
1M ago
HALO
Closing Bell Movers: Progress Software slips 4% after earnings
Premium
The Fly
Closing Bell Movers: Progress Software slips 4% after earnings
2M ago
CXW
DYN
Halozyme added to Russell 1000 Index
PremiumThe Fly
Halozyme added to Russell 1000 Index
2M ago
HALO
Halozyme says Argenx received EU approval for Vyvgart with Enhanze for CIDP
PremiumThe Fly
Halozyme says Argenx received EU approval for Vyvgart with Enhanze for CIDP
2M ago
ARGX
HALO
PGR institution likely weakens Halozyme bull case scenario, says Wells Fargo
PremiumThe Fly
PGR institution likely weakens Halozyme bull case scenario, says Wells Fargo
2M ago
MRK
HALO
Merck granted review of Halozyme patent claims by PTAB
PremiumThe Fly
Merck granted review of Halozyme patent claims by PTAB
2M ago
MRK
HALO
Halozyme’s Strategic Positioning and Market Potential Drive Buy Rating
PremiumRatingsHalozyme’s Strategic Positioning and Market Potential Drive Buy Rating
3M ago
HALO
Halozyme announces EC approval of Bristol Myers’ Opdivo developed with Enhanze
Premium
The Fly
Halozyme announces EC approval of Bristol Myers’ Opdivo developed with Enhanze
3M ago
BMY
HALO
Optimistic Buy Rating for Halozyme Amid Price Control Concerns
Premium
Ratings
Optimistic Buy Rating for Halozyme Amid Price Control Concerns
3M ago
HALO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >